FDA Inspection 1191818 - Intas Pharmaceuticals Limited - December 02, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Intas Pharmaceuticals Limited, with an inspection on December 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Intas Pharmaceuticals Limited
Inspection Date: December 2, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · c40b512c-7d12-45b2-bbd7-edc2eba3727a

Violation Codes10

21 CFR 211.100(a)21 CFR 211.113(b)21 CFR 211.160(a)21 CFR 211.165(e)21 CFR 211.166(a)21 CFR 211.19221 CFR 211.194(a)21 CFR 211.22(d)21 CFR 211.42(c)(10)(iv)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.